SCHEMBL20048949

SCHEMBL20048949

Cc1cnc2cc(C(C)C)cc(F)c2n1

nearest known ligand 0.31

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.31
HRH4 Q9H3N8 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31
AKR1C3 P42330 1/20 0.31
AKR1C2 P52895 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20049258 0.83 AKR1C3 (0.31) AKR1C3AKR1C2
SCHEMBL20049296 0.80 ALDH1A1 (0.33) KCNH2HRH4HRH3
SCHEMBL20047653 0.80
SCHEMBL20049293 0.73 KCNH2 (0.33) KCNH2HRH4HRH3
SCHEMBL20049379 0.71
SCHEMBL20049295 0.70 NPC1 (0.41)
SCHEMBL14652456 0.70 NPC1 (0.41)
SCHEMBL20049057 0.70 NOS3 (0.37)
SCHEMBL20047594 0.68
SCHEMBL24019234 0.68 OGA (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018067704-A1 ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. (US) 2018-04-12 WO disclosed